Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Hypertension and Diastolic Dysfunction
NCT00170924Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diastolic dysfunction and hypertension (HTN) comparing Valsartan with Placebo (2 arms). Primary endpoint: Change from baseline in diastolic heart function at 38 weeks. Started Aug 2004; status: completed.
02
Drugs
valsartan
03
Conditions
diastolic dysfunctionhypertension (HTN)
Beyond the preview
Go deeper on NCT00170924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170924.